D-0276-2015 Class II Terminated

Recalled by Baxter Healthcare Corp. — Deerfield, IL

FDA drug recall D-0276-2015 was initiated by Baxter Healthcare Corp. on Oct 30, 2014 and is designated Class II. Reason for recall: Subpotent Drug: Heparin raw material was found to have low potency The recall status is terminated (terminated Sep 22, 2016). Affected quantity: 127,746 Viaflex Plus Container.

Recall Details

Product Type
Drugs
Report Date
Dec 3, 2014
Initiation Date
Oct 30, 2014
Termination Date
Sep 22, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
127,746 Viaflex Plus Container

Product Description

Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx only, Manufactured for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015 by Baxter Healthcare Corporation 250 Road 144 Jayuya, Puerto Rico, 00664, NDC 0338-0431-03

Reason for Recall

Subpotent Drug: Heparin raw material was found to have low potency

Distribution Pattern

Nationwide

Code Information

Lot #: N003061; N003079; and N003087, Exp 2/29/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0276-2015
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.